MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
Direct factory supply of precision-engineered single-use medical devices validated for clinical efficiency, strict sterility assurance, and international compliance.
Comprehensive peripheral IV catheter range featuring ISO 10555 color-coded hubs, Japanese stainless steel needle, and biocompatible PTFE/FEP catheter tube.
Hospital-grade sterile peripheral catheter designed for routine clinical infusion. Features high flow-rate geometry and transparent chamber for rapid flashback confirmation.
Flexible winged needle assembly crafted for veterinary venous placement. Dual flexible wings provide firm anchoring on animal limbs during continuous fluid therapy.
High-flow 18G winged catheter integrating a color-coded non-return injection port and standard Luer lock connection, suitable for rapid fluid replacement.
Fine-gauge pediatric and small animal intravenous catheter tubes designed for feline and canine care, preventing vein trauma during repeated administration.
Bulk wholesale IV catheter system configured with quick blood response chamber. Built for mass tender supply, emergency departments, and healthcare networks.
Safety-engineered veterinary catheter with passive needle protection to minimize accidental needle-stick hazards among veterinary clinicians during animal handling.
Comprehensive veterinary cannula series spanning large-animal resuscitation to small-pet therapy. Standardized color coding ensures instant gauge recognition.
In modern vascular access management, the heparin cap (commonly referred to as a yellow injection stopper or heparin closure cap) serves as a critical sterile barrier and injection port. Attached to the proximal hub of peripheral IV cannulas, central venous catheters (CVC), three-way stopcocks, or extension lines, heparin caps maintain lumen patency through intermittent heparinized saline flushes while guarding against retrograde blood flow and microbial ingress.
As an established CE certified heparin cap supplier and exporter, our manufacturing philosophy adheres to strict biomedical engineering standards. Every injection stopper is crafted to withstand repeated needle punctures, high-fluid pressure loads, and aggressive chemical exposure without losing mechanical seals or leaching harmful phthalate plasticizers into the fluid pathway.
The performance of an intravenous heparin cap depends directly on the purity and elasticity of its constituent polymers. Our heparin caps are manufactured using medical-grade raw materials certified under ISO 10993 testing:
High-clarity, fracture-resistant medical-grade polycarbonate provides structural rigidity, transparent fluid inspection, and crack resistance against alcohol swabs and lipids.
Latex-free synthetic polyisoprene stopper offers superior self-sealing elasticity. It withstands up to 100 hypodermic needle punctures without coring or fluid leakage.
Precision inner fluid cavity engineered to hold less than 0.04 mL residual volume, drastically reducing blood stasis, bacterial colonization, and drug mixing errors.
To satisfy tender specifications for global health authorities, every production lot undergoes rigorous laboratory verification prior to Ethylene Oxide (EO) sterilization release:
| Technical Parameter | Industry Benchmark / Standard | Factory Specification Value |
|---|---|---|
| Luer Fitting Standard | ISO 80369-7 / ISO 594 | 6% Male & Female Luer Lock Compatible |
| Internal Priming Volume | < 0.10 mL | 0.04 mL Ultra-Low Dead Space |
| Pressure Hydrostatic Rating | 2.0 Bar (30 psi) | ≥ 3.0 Bar (43.5 psi) Leak-Free |
| Septum Puncture Life | 50 Penetrations | ≥ 100 Penetrations (21G Needle, Non-Coring) |
| Biocompatibility Compliance | ISO 10993-1, 5, 10, 11 | Cytotoxicity-Free, Non-Pyrogenic, DEHP-Free |
| Sterilization Validation | ISO 11135 (EO Gas) | SAL 10⁻⁶ (Sterility Assurance Level) |
As global hospital networks, health ministries, and private medical groups elevate infection control mandates, the global procurement landscape for IV accessories and heparin caps is undergoing a structural transition. Sourcing directors and biomedical importers must align their procurement strategies with four key regulatory and market evolution drivers:
Regulatory bodies across Europe (EU MDR 2017/745) and North America are enforcing strict bans on DEHP plasticizers and natural rubber latex. Future hospital tenders require 100% synthetic latex-free and phthalate-free polymers to mitigate endocrine disruption and severe allergic reactions.
While classic yellow heparin caps remain essential for cost-sensitive regional markets, tier-one hospital systems are increasingly pairing heparin caps with split-septum needleless connectors and positive displacement valves to drastically cut Catheter-Related Bloodstream Infections (CRBSI).
Post-pandemic procurement favors manufacturers who maintain direct control over raw material compound formulation, cleanroom molding, and in-house sterilization over trading intermediaries. Direct factory sourcing minimizes lead-time volatility and batch inconsistency.
With over two decades of specialized medical manufacturing, Lars Medicare delivers turnkey OEM and contract manufacturing solutions to global distributors, pharmaceutical companies, and health ministries.
Our state-of-the-art facility in Sonepat, Haryana incorporates high-precision mold tooling, high-speed injection molding cleanrooms, automated assembly, and validated Ethylene Oxide (EO) sterilization chambers under one roof.
Our quality management system is audited and certified to European Medical Device Directive (CE) and ISO 13485 standards. Every batch is backed by comprehensive Certificate of Analysis (CoA) and sterilization validation reports.
We supply single-use medical consumables to over 379 distributors across Europe, Latin America, Africa, the Middle East, and Asia-Pacific. Our logistics hubs in New Delhi, Sonepat, and Milton (Canada) guarantee smooth container consolidation.
From custom color-coding, gauge selection, packaging blister design, to UDI barcoding and multilingual Instructions for Use (IFU), our engineering desk translates distributor requirements into market-ready products.
Request technical specification sheets, sample packs, regulatory dossiers, and competitive FOB/CIF price quotes directly from our OEM export division.
Get CatalogAnswers to common regulatory, technical, and commercial queries raised by global healthcare purchasing managers.
Every export shipment from Lars Medicare is accompanied by a complete regulatory documentation package including the CE Certificate of Conformity, ISO 13485:2016 Quality Management System Certificate, Certificate of Free Sale (CFS), batch-specific Certificate of Analysis (CoA), EO Sterilization Validation Report, and ISO 10993 Biocompatibility test summaries. Technical Construction Files (TCF) are available to assist distributors with fast-track national product registration in target countries.
Yes. Our heparin caps are manufactured using 100% virgin medical-grade Polycarbonate (PC) for the rigid female Luer lock body, and a high-elasticity synthetic Polyisoprene rubber for the self-sealing injection septum. The entire assembly is 100% natural rubber latex-free, DEHP-free, and non-pyrogenic, eliminating chemical toxicity risks for pediatric, neonatal, and long-term infusion applications.
Yes, OEM and private-label manufacturing is a core enterprise service. We offer customized packaging including OEM medical-grade paper-poly blister pouches, inner boxes, shipper cartons, multilingual IFUs, and UDI barcode integration. Minimum Order Quantities (MOQ) for standard neutral packaging start at 10,000 units, while full custom OEM artwork orders typically start at 50,000 to 100,000 units depending on packaging specifications.
Our heparin caps utilize a high-density synthetic polyisoprene septum with memory-retention molecular structures. When pierced by standard 18G to 26G hypodermic needles, the elastomeric matrix compresses around the shaft to prevent micro-leakage. Upon needle withdrawal, the septum instantly self-reseals, retaining hydrostatic burst strength exceeding 3.0 Bar (43.5 psi) for up to 100 penetration cycles.
Standard catalogue orders in neutral packaging ship within 2 to 3 weeks from order confirmation. First-time private-label OEM orders require 4 to 5 weeks to complete artwork approval, mold printing, assembly, EO sterilization, and QC release. We quote under FOB (Nhava Sheva, Mundra, or Delhi Air Cargo), CIF (Sea/Air to destination port), and DDP terms for select regions.
Sterile heparin caps should be stored in a clean, cool, and dry warehouse away from direct sunlight, chemical vapors, and extreme heat (recommended temperature range: 5°C to 35°C, relative humidity < 80%). When kept in uncompromised original blister packaging, the product maintains a validated sterile shelf-life of 5 years from the date of Ethylene Oxide (EO) sterilization.